Table 2.
Analyte | Not detectable | Detectable
|
P trend‡ | P quadratic | |||
---|---|---|---|---|---|---|---|
<25th† | 25th to <50th | 50th to <75th | ≥75th | ||||
PBB-153 | |||||||
Median serum concentration (ng/g of lipid) | — | 1.2 | 2.3 | 3.8 | 13.1 | ||
Cases/n | 11/166 | 16/306 | 39/303 | 41/292 | 49/300 | ||
Adjusted OR (95% CI) | Referent | 0.7 (0.3–1.6) | 1.4 (0.7–3.0) | 1.6 (0.8–3.5) | 1.9 (0.9–4.0) | <0.01 | 0.88 |
PBDE-28 | |||||||
Median serum concentration (ng/g of lipid) | — | 0.7 | 1.2 | 2.0 | 5.4 | ||
Cases/n | 37/279 | 19/296 | 32/262 | 31/259 | 37/271 | ||
Adjusted OR (95% CI) | Referent | 0.5 (0.3–1.0) | 1.2 (0.7–2.0) | 0.9 (0.5–1.6) | 0.8 (0.5–1.4) | 0.93 | 0.97 |
PBDE-47 | |||||||
Median serum concentration (ng/g of lipid) | — | 6.5 | 13.7 | 28.2 | 73.3 | ||
Cases/n | 2/36 | 43/333 | 34/333 | 40/332 | 37/333 | ||
Adjusted OR (95% CI) | Referent | 3.4 (0.8–15.7) | 2.9 (0.6–13.5) | 3.8 (0.8–17.4) | 2.7 (0.6–12.5) | 1.00 | 0.16 |
PBDE-99 | |||||||
Median serum concentration (ng/g of lipid) | — | 3.1 | 5.3 | 9.2 | 26.9 | ||
Cases/n | 45/456 | 37/231 | 25/222 | 22/230 | 27/228 | ||
Adjusted OR (95% CI) | Referent | 2.0 (1.2–3.2) | 1.5 (0.9–2.6) | 1.2 (0.7–2.2) | 1.3 (0.7–2.2) | 0.57 | 0.06 |
PBDE-100 | |||||||
Median serum concentration (ng/g of lipid) | — | 1.4 | 2.8 | 5.6 | 16.8 | ||
Cases/n | 10/94 | 37/330 | 37/305 | 35/322 | 37/316 | ||
Adjusted OR (95% CI) | Referent | 1.3 (0.6–2.8) | 1.6 (0.7–3.5) | 1.6 (0.7–3.5) | 1.4 (0.6–3.0) | 0.50 | 0.20 |
PBDE-153 | |||||||
Median serum concentration (ng/g of lipid) | — | 1.9 | 3.6 | 6.6 | 24.6 | ||
Cases/n | 9/101 | 34/317 | 40/314 | 42/316 | 31/319 | ||
Adjusted OR (95% CI) | Referent | 1.6 (0.7–3.6) | 2.6 (1.2–5.8) | 2.7 (1.2–6.0) | 1.8 (0.8–4.0) | 0.15 | <0.01 |
Adjusted for age, sex, race, poverty income ratio, and BMI.
Displayed is the median serum concentration in each category.
P trend was calculated without a quadratic term in the model, while P quadratic was calculated including the linear term.